ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,671.80
      1.35%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      01/03/20178:00AMGlobeNewswire Inc.Aclaris to Present at 35th Annual J.P. Morgan Healthcare ConferenceNASDAQ:ACRSAclaris Therapeutics Inc
      12/21/201611:58AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      12/21/201611:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/20/20166:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/20/20166:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/20/20166:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/20/20166:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/19/20165:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/19/20165:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/19/20165:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/19/20165:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/19/20165:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      12/07/20168:00AMGlobeNewswire Inc.Aclaris Therapeutics Initiates Phase 1 Clinical Trial for ATI-50001, an Investigational JAK Inhibitor, for the Treatment of A...NASDAQ:ACRSAclaris Therapeutics Inc
      12/02/20166:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACRSAclaris Therapeutics Inc
      11/28/20164:17PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ACRSAclaris Therapeutics Inc
      11/22/20168:00AMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      11/21/20165:29PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACRSAclaris Therapeutics Inc
      11/18/20164:15PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ACRSAclaris Therapeutics Inc
      11/18/20164:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/18/20166:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRSAclaris Therapeutics Inc
      11/17/20167:03PMGlobeNewswire Inc.Aclaris Announces Pricing of Public Offering of Common StockNASDAQ:ACRSAclaris Therapeutics Inc
      11/17/20166:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRSAclaris Therapeutics Inc
      11/16/201610:10PMGlobeNewswireAclaris Therapeutics vermeldet positive Top-Line-Ergebnisse der Phase 3 für A-101 zur Behandlung von seborrhoischer Keratose...NASDAQ:ACRSAclaris Therapeutics Inc
      11/16/201610:10PMGlobeNewswireAclaris Therapeutics annonce des résultats de phase 3 positifs de premier ordre pour le A-101 dans le traitement de la kéra...NASDAQ:ACRSAclaris Therapeutics Inc
      11/16/20164:05PMGlobeNewswire Inc.Aclaris Announces Proposed Public Offering of Common StockNASDAQ:ACRSAclaris Therapeutics Inc
      11/15/20164:32PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ACRSAclaris Therapeutics Inc
      11/15/20164:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/15/20164:08PMGlobeNewswireAclaris Therapeutics Announces Positive Top-Line Phase 3 Results for A-101 In Treating Seborrheic Keratosis, a Common Undertr...NASDAQ:ACRSAclaris Therapeutics Inc
      11/15/20164:08PMGlobeNewswire Inc.Aclaris Therapeutics Announces Positive Top-Line Phase 3 Results for A-101 In Treating Seborrheic Keratosis, a Common Undertr...NASDAQ:ACRSAclaris Therapeutics Inc
      11/15/20166:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS

      Your Recent History

      BIT
      UB30FE
      UniCredit Bank
      Delayed Upgrade Clock